Objective: The objective of the study was to determine the effect of transurethral resection of prostate (TURP) on the quality of life (QOL) and urinary symptoms on patients with benign prostatic hyperplasia (BPH) at Jose R. Reyes Memorial Medical Center using the International Prostatic Symptom Score (IPSS) and global quality of life symptom and Health Related Quality of Life Short Form (SF-12) questionnaires.

Materials and Methods: A prospective, observational study on patients without significant co-morbidities who underwent TURP for benign prostatic hyperplasia. The patients were given series of questionnaires: The International Prostate Symptom Score (IPSS) and Global quality of life symptom and Health Related Quality of Life Short Form (SF-12) questionnaire. The questionnaires were completed a day prior the operation as a baseline, 1st, 2nd, and 3rd month post-operatively. Data were gathered and analyzed.

Results: November 2007 to July 14, 2008, 52 patients diagnosed to have benign prostatic hyperplasia underwent transurethral resection of prostate in saline solution (TURIS). The health related quality of life SF12 questionnaire, and IPSS showed that scores on all questions significantly improved from pre-operative to the 3rd month post-operatively.

Conclusion: TURP remains the treatment of choice for men with acute urinary retention secondary to benign prostatic hyperplasia because of its effectiveness for improving the voiding symptoms and overall quality of life.

Transurethral Resection Of Prostate ; Quality Of Life ; Benign Prostatic Hyperplasia

Background: Benign hyperplasia prostate is a common disease in older men (over 60 years old). Transurethral resection of benign hyperplasia prostate is a method of improving symptoms with the best results, though with a high rate of complications, in which the most serious complication is transurethral prostatectomy syndrome (TURPS). Objective: The study aimed to describe clinical and para-clinical characteristics of TURPS and to define some risk factors of TURPS. Subject and methods: A descriptive, prospective study was conducted in 200 patients, who underwent TURPS, ASA I-II at the Anesthetic Emergency Department, Viet Duc Hospital from April 2007 to October 2007. To describe TURPS by observing clinical signs and serum sodium. The risks of TURPS were considered as prostate weight, operation time and amounts of used irritants. Results: The incidence of the TURPS was 7% of all resections. Clinical signs of the TURPS were nausea, vomiting, headaches, confusion and disorientation. TURPS was associated with hypotension (42.9%), bradycardia (35.7%), increased CVP (21.4%). The sodium concentration fell below normal in certain patients (64.3%). The amount of 3% Sorbitol (> 20 liters) was an independent risk factor of TURPS, but not the prostate weight or the operation time. Conclusions: The main signs of TURPS included central nervous symptoms (100%), circulatory and respiratory disorders (42.9%, 21.4%, respectively) and hyponatremia (64.3%). Sorbitol 3% > 20 liters was an independent risk factor of TURPS.
Transurethral Prostatectomy Syndrome ; benign hyperplasia prostate